Structured relearning of activities of daily living in dementia: the randomized controlled REDALI-DEM trial on errorless learning. by Voigt-Radloff, Sebastian et al.
RESEARCH Open Access
Structured relearning of activities of daily
living in dementia: the randomized
controlled REDALI-DEM trial
on errorless learning
Sebastian Voigt-Radloff1†, Maartje M. E. de Werd2†, Rainer Leonhart4, Danielle H. E. Boelen2,5,
Marcel G. M. Olde Rikkert3, Klaus Fliessbach6,7, Stefan Klöppel1,8, Bernhard Heimbach1, Andreas Fellgiebel9,
Richard Dodel10,11, Gerhard W. Eschweiler12, Lucrezia Hausner13, Roy P. C. Kessels2,14* and Michael Hüll1,8
Abstract
Background: Errorless learning (EL) is a method for optimizing learning, which uses feed-forward instructions in
order to prevent people from making mistakes during the learning process. The majority of previous studies on EL
taught patients with dementia artificial tasks of little or no relevance for their daily lives. Furthermore, only a few
controlled studies on EL have so far been performed and just a handful of studies have examined the long-term
effects of EL. Tasks were not always trained in the patients’ natural or home environment, limiting the external
validity of these studies. This multicenter parallel randomized controlled trial examines the effects of EL compared
with trial and error learning (TEL) on the performance of activities of daily living in persons with Alzheimer’s or
mixed-type dementia living at home.
Methods: Patients received nine 1-hour task training sessions over eight weeks using EL or TEL. Task performance
was measured using video observations at week 16. Secondary outcome measures were task performance
measured at week 26, satisfaction with treatment, need for assistance, challenging behavior, adverse events,
resource utilization and treatment costs.
Results: A total of 161 participants were randomized, of whom 71 completed the EL and 74 the TEL arm at week 11.
Sixty-nine EL patients and 71 TEL patients were assessed at the 16-week follow-up (the primary measurement
endpoint). Intention-to-treat analysis showed a significantly improved task performance in both groups. No significant
differences between the treatment groups were found for primary or secondary outcomes.
Conclusions: Structured relearning improved the performance of activities of daily living. Improvements were
maintained for 6 months. EL had no additional effect over TEL.
Trial registration: German Register of Clinical Trials DRKS00003117. Registered 31 May 2011.
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Background
The increasing deterioration of cognitive and daily func-
tioning in Alzheimer’s dementia (AD) causes the main
burden for patients, their caregivers and society, while
options for disease-modifying treatments are still lacking
[1, 2]. Evidence from systematic reviews of small-scale
clinical trials suggests that structured teaching tech-
niques may optimize or even stabilize daily functioning
in AD [3–5]. Errorless learning (EL) is a prominent
method for optimizing learning, which uses feed-
forward instructions in order to prevent people from
making mistakes during the learning process. It is
assumed that by preventing errors during learning, the
limited cognitive capacity of AD patients is directed
toward the acquisition of the correct steps of a task,
without interference of occurring errors [4]. The ration-
ale behind EL is that explicit memory is responsible for
recognizing and correcting the errors that are made
during learning. In people with AD who have profound
deficits in explicit memory, these errors may not be
recognized as such and are therefore not corrected, but in-
stead are implicitly consolidated into long-term memory.
EL may include different techniques such as graded tasks
broken down into small steps, modeling, encouragement
not to guess, anticipating errors and immediate correction,
prompts when steps are performed successfully, vanishing
cues and spaced retrieval (rehearsal of the retrieval of in-
formation using increasing time intervals) [4, 5].
A meta-analysis on the treatment effects of EL and the
method of vanishing cues in amnesic patients (N = 192)
showed a large and beneficial effect for the EL treatment
compared with trial and error learning (TEL) [3]. A
qualitative review [5] included 26 studies on teaching
persons with dementia daily tasks or skills. Five con-
trolled group studies and 12 single-case studies obtained
significantly superior effects of EL immediately after
training compared with TEL or a no-treatment con-
dition. Seventeen studies showed maintenance of EL
effects at follow-up. Clare and Jones [4] performed a
critical review including 15 empirical studies using
group designs to compare the efficacy of EL and errorful
learning in persons with brain injury or dementia. These
authors argued that EL may be particularly beneficial in
individuals with severe memory impairments. They con-
cluded that benefits of EL for persons with early-stage
and moderate dementia are mixed, with some studies
finding an EL benefit and others reporting no additional
advantage of EL.
The majority of previous studies taught dementia pa-
tients artificial tasks of little or no relevance for patients
in daily life. Furthermore, only a few controlled studies
on EL have so far been performed and just a handful of
studies have examined the long-term effects of EL.
Moreover, large differences were found across studies in
the types of tasks that were taught and the exact
errorless teaching methods that were used. Tasks were
not always trained in the patients’ natural or home
environment, limiting the external validity of these
studies. Therefore we conducted the REDALI-DEM trial
(RElearning methods on DAily LIving task performance
of persons with DEMentia), a multisite randomized con-
trolled trial (RCT) with the aim of comparing the effects
of EL vs TEL on the performance of activities of daily
living in persons with mild to moderate dementia living
at home. Based on earlier studies [4, 5] we hypothesized
that EL is superior compared with TEL.
Secondary questions of interest were as follows: can
effects on performance be maintained for six months?
Does relearning of daily living tasks show transfer effects
to the patients’ initiative or need for assistance in
activities of daily living? What are the treatment costs?
How is the treatment accepted by patients? What
adverse events occur during the treatment period?
Methods
Design
We used a six-center, single-blind, active-controlled de-
sign with a 1:1 randomization for two parallel groups to
compare the effects of EL and TEL. The study was re-
gistered in the German Register of Clinical Trials
(DRKS00003117), which is connected to the International
Clinical Trials Registry Platform. The a-priori published
study protocol is available elsewhere [6]. Prior to the RCT,
a pilot study was performed in which the study procedure
including the EL and TEL interventions was evaluated
and monitored. The practical issues and difficulties that
the therapists encountered were discussed, leading to
minor protocol amendments after the 6-month trial pilot
phase and before the start of recruitment; these concerned
the participating study sites (two resigned due to
organizational reasons, and to safeguard sufficient power
a new site was included), inclusion criteria (the threshold
for the need for assistance in activities of daily living was
increased), intervention procedures (time to select train-
ing activities was extended from one to three sessions; the
number of refresher sessions was reduced from three to
two; special cue card series were not used in the EL arm)
and outcome measurement (the task performance scale
(TPS) was specified).
Previously available outcome measures to assess task
performance have not been investigated with respect to
reliability and construct validity in naturalistic settings
using daily-life tasks. This pilot phase was therefore also
used to validate the newly developed outcome measure:
the Core Elements Method (CEM). The interrater reli-
ability and concurrent validity of the CEM and TPS were
analyzed and compared [7]. Based on these results, the
TPS and CEM were found to be equally valid for the
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assessment of task performance in people with dementia.
However, the CEM was found to be less complex and
less time-consuming compared with the TPS, and was
therefore used in the current RCT.
Participants and setting
Persons living at home and diagnosed with mild to mod-
erate AD or mixed-type dementia (Mini Mental State
Examination (MMSE) [8] scores between 14 and 24)
were eligible. Informed consent from both the patient
and the primary caregiver was required. A caregiver had
to be available for rating the need for assistance in activ-
ities of daily living. For inclusion, the mean score of the
five household items in the performance scale of the
Interview for Deterioration in Daily Living Activities in
Dementia (IDDD) [9] had to be 2.5 or higher.
Exclusion criteria were major depression (Geriatric
Depression Scale—Short Form (GDS-15) ≥ 9) [10], major
need for physical nursing care (≥120 min per day) as
well as severe behavioral disturbances, unstable medical
conditions or lack of attention and understanding of in-
structions in German as judged by the recruiting study
physician and involvement in other clinical trials.
The REDALI-DEM study sites were six outpatient
memory centers at university hospitals; they are located
throughout Germany in urban regions with catchment
areas of about 100,000 (Marburg and Tübingen), 300,000
(Freiburg and Mainz) and 400,000 (Bonn and Mannheim)
inhabitants, and all centers have provided outpatient
dementia care for 5–17 years. The standard service of the
study sites comprised a diagnostic work-up for dementia
and related diagnoses as well as recommendations for risk
reduction, dementia medication and nonpharmacological
treatments. Principal investigators from the centers were
psychiatrists, neurologists or geriatricians with long-
standing experience in dementia care.
Procedures
After patient recruitment, the site investigator requested
randomization via email. Within 48 hours, the trial stat-
istician at a detached site provided a 1:1 randomization
(computer-generated, block sizes varying at random, no
stratification) for each individual case. Independent
assessors were blinded to group assignment. Blinded
assessment of the treatment effects was ensured by
videotaping the task performance and removing all hints
of the treatment modality. Experimental and control
interventions included the same amount of personal
involvement. Neither patients nor therapists were pre-
sented with an assumption as to which intervention may
be more likely to improve activities of daily living. At
week 0, trial physicians completed the baseline assess-
ment (t0) at the study center and patients were random-
ized. At weeks 1 and 2, the therapists selected two tasks
that were relevant for the patient in daily life, but which
he/she was no longer able to perform independently to-
gether with the patients and his or her caregiver. The
baseline task performance was then videotaped. From
weeks 3 to 10, patients received nine 1-hour training
sessions at home. Task performance was videotaped
again at week 11 (t1), week 16 (t2, primary outcome
measure) and week 26 (t3). Therapists carried out two
1-hour refresher training sessions in weeks 19 and 20.
Trial physicians completed the follow-up assessments at
the study center in weeks 16 and 26 (see Table 1 for the
intervention scheme).
Interventions
Two separate treatment manuals for EL or TEL have
been developed, pilot-tested, adapted and taught in
introductory seminars. Per study site, we trained at least
three therapists (occupational therapist, nurse, psycholo-
gist or social worker). To minimize contamination, we
separated the main therapists for EL from the main
therapists for TEL while teaching the experimental and
control treatment protocols. The third therapist received
both EL and TEL training, serving as a substitute; this
person was not allowed to carry out more than four
sessions per patient. To reduce selection bias, we assigned
interventionists to EL, TEL or substitute at random.
By shared decision-making, the therapist and the patient
selected two training tasks relevant for the patient’s daily
living. The two selected tasks were referred to as task A
and task B respectively (note that these two tasks were
thus different for each patient). To do so, they used a cata-
log of 43 predefined tasks (20 household tasks such as
doing the dishes or laying a table, 11 leisure tasks such as
performing light physical exercise or taking photographs,
12 cognitively challenging tasks such as finding a bus
connection or surfing the Internet). Tasks had to be
independent from changing seasons or environments (e.g.,
not shoveling snow, not using equipment that will be
renewed soon) and repeatable within 30 min (e.g., not pre-
paring an extensive meal). Within the first three 1-hour
sessions the tasks had to be selected and checked for rele-
vance and the patient’s performance level had to show
room for improvement (50–75% insufficient performance).
Each therapist’s session consisted of 1 hour for the ac-
tual training (30 min each for task A and task B) and
1 hour for documentation and travel time. If patients
expressed concerns, therapists could reduce the training
time to engage in motivating conversation. For the train-
ing, existing home equipment and no extra materials
were used. Caregivers were not present during training.
Errorless learning (experimental arm)
The therapist divided the task into appropriate steps,
demonstrated and explained the first step, asked the
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patient to perform the first step and accompanied the
patient’s step performance by continuous verbal instruc-
tion. As soon as the therapist anticipated a potential
error, he/she intervened by giving a short demonstration
of the correct performance. When the patient had per-
formed the first step correctly, the therapist demon-
strated and instructed the next step. These procedures
of instruction, performance and early intervening to
avoid errors were followed until the whole task was per-
formed. The training stopped after 30 min, irrespective
of how often the task or its individual steps were per-
formed. After the fifth session, the therapist was allowed
to reduce the amount of modeling and verbal instruc-
tion, but had to provide it again as soon as the patient
showed potential errors, hesitated or showed uncertainty
in performing the task (Table 2).
Trial and error learning (control arm)
The therapist asked the patient to perform the task and
did not provide any instruction or demonstration. When
the patient made an error, he/she was allowed to guess to
self-correct. In the first 10-min period of the training, the
therapist did not provide any support, apart from observ-
ing with interest and intervening if the patient showed
signs of irritation or frustration. In the second training
phase, the therapist used open-ended questions about the
purpose of the task after three insufficient trials to find so-
lutions. If the patient was still unable to perform the step,
the therapist gave verbal instructions but did not demon-
strate the step. This procedure of the patient performing
and guessing, the therapist’s supporting open-ended ques-
tions and—if necessary—correct instructions was contin-
ued until the whole task was performed or the training
stopped after 30 min (Table 2).
Intervention adherence
Masked external raters assessed the intervention adher-
ence by rating videos of two treatment sessions, one at the
beginning and one at the end of the treatment series, for
two patients of each therapist. In addition, therapists
commented and self-rated their therapeutic interaction,
dealing with errors and protocol adherence for each pa-
tient after a treatment series was completed in week 11.
External ratings and self-ratings were scored on the same
six-point scale (1 = excellent job; 6 = poor treatment).
Outcome measures
Task performance was defined as the primary patient-
related outcome measure and assessed using the CEM. All
tasks of the catalog were subdivided into core elements and
illustrated with detailed descriptions (see Table 3 for an ex-
ample of an activity, its core elements and the individual
steps). Therapists adapted this description to the individual
context in the patient’s home and specified the required
steps to successfully perform each core element of each
chosen task. The blinded assessors used these descriptions
to rate the patient’s actual performance of each core elem-
ent using a seven-point scale for each task (1 = not per-
formed at all as trained by the therapist; 7 = performed
exactly as trained by the therapist) [7].
Secondary outcomes were daily functioning as measured
with the IDDD [11], resource utilization (Resource
Utilization in Dementia (RUD)) [12, 13] and satisfaction
with treatment measured with a verbal rating scale (ranging
from 1 = very satisfied to 5 = very unsatisfied). Furthermore,
we assessed several control measures: cognitive status
(MMSE [8]), dementia stage (Reisberg Clinical Dementia
Rating), challenging behavior assessed by the Neuropsychi-
atric Inventory (NPI) [14, 15] and treatment costs using a
Table 1 Intervention scheme
Weeks 0–2 Weeks 3–10 Week 11 Week 16a Weeks 19–20 Week 26
Measurement t0 – t1 t2 – t3
Intervention – Nine sessions Break Two refresher sessions –
aPrimary outcome measure
Table 2 Overview of the errorless learning (EL) and trial and error learning (TEL) arms of the intervention
EL intervention TEL intervention
– Task is divided into core elements
– Each step is demonstrated by the therapists accompanied with verbal
instructions
– The patient is then invited to perform the task step, and is verbally guided
by the therapists
– Only when the patient performs the first step correctly does the therapist
demonstrate and instruct the next step
– In case of hesitation or (near) error by the patient, the step is repeated again
and the sequence is also repeated again (both with demonstrating and
verbal instructions by the therapist)
– From session six onward it is allowed to fade out help
– The patient must try to perform the task by himself/herself for the
first 10 min, regardless of the amount of errors or hesitations
– Intervention is only allowed within the first 10 min when the
patient becomes irritated or frustrated
– After 10 min, intervention is allowed using a stepwise approach:
1. Stimulating the patient by asking open questions
2. Summarizing what has already been done and what the task
goal is
3. Giving clear verbal instruction
4. Demonstrating the task steps
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cost unit rate of €60 per treatment hour including all costs
(personnel, material, travel, overheads). In the case of group
differences, these control measures can be used to adjust
for potential confounding. Death, nursing home admissions
and nonelective hospital admissions were defined as serious
adverse events.
Statistical analyses
A sample size of 80 participants per treatment arm was
calculated for the detection of small effect sizes (f = 0.10)
in an analysis of variance with two groups and two re-
peated measurements at baseline and week 16 hypothe-
sizing α = 0.05, a power of 0.8 and a correlation of 0.6
between the measurement points (total n = 160). Overall
efficacy of treatment was assessed by conducting multi-
variate analysis of covariance (ANCOVA) controlling for
pretreatment scores on all outcome measures and con-
sidering all standards for the testing of assumptions. The
multivariate analyses were done separately for primary
and secondary outcomes because of the different num-
bers of measurement points. For the primary outcome,
we performed an intention-to-treat (ITT) analysis on all
randomized patients not dropped out at week 16. We
used 10 multiple imputations with the Full Information
Maximum Likelihood method when data were missing
in single items or scales at week 16 or week 26 and for
complete dropouts at week 26. The missing-data mech-
anism is ignorable if data are missing at random [16].
Missing data can be considered Missing Completely At
Random (MCAR) if the probability that data are missing
does not depend on observed or unobserved data. We
used Little’s MCAR test to examine whether our missing
pattern was completely at random. The control
measures cognitive status (MMSE [8]), dementia stage
(Reisberg Clinical Dementia Rating) and challenging
behavior (NPI) [14, 15] were analyzed for group
differences at baseline and after the intervention. We
used SPSS 23.0 and a two-tailed α = 0.05 for all statis-
tical analysis.
Results
Recruitment, patient flow and baseline characteristics
The recruitment period lasted 3.5 years from April 2012
to September 2015. Two initial study sites received
introduction and training but could not recruit patients;
one site due to lack of access to eligible patients, one site
because one trained therapist decided to withdraw.
Thereafter, a new study site (Mannheim) was recruited
and enrolled their first patient in May 2013.
From 161 randomized participants, 140 and 137
respectively received a follow-up assessment at week 16
and week 26 (attrition rate 13.0% and 14.9%; Fig. 1).
Reasons for drop out were death (1 EL; 1 TEL), nonelec-
tive admission to hospital (1 EL; 2 TEL), admission to
nursing home (2 EL; 2 TEL) and withdrawal (9 EL; 6
TEL). Group differences in the baseline characteristics of
patients, caregivers and therapists were clinically not
relevant (Table 4 and Additional file 1: Table S1).
Intervention delivery and adherence
From the 81 randomized patients in the EL group, all ses-
sions were completed in full for 71 persons. In five cases,
not all sessions were completed but a sufficient number
(≥9 sessions) was completed. In another five cases, an
insufficient number of sessions (three, four, five, five or six
sessions) had taken place. From the 80 cases randomized
to TEL, the intervention was fully completed in 74 cases
and sufficiently completed in two cases (≥9 sessions). Four
cases received an insufficient treatment (three, four, five or
six sessions). No patient changed from the EL to TEL
condition or from the TEL to EL condition.
Tasks that were trained the most included following
written instructions to perform light exercises (23 EL, 27
TEL), making a telephone call (15 EL, 17 TEL), selecting a
specific TV broadcast (11 EL, 16 TEL), writing a shopping
list (9 EL, 15 TEL), finding a telephone number (6 EL, 16
TEL), playing a DVD (11 EL, 1 TEL), playing a CD at a
convenient volume (9 EL, 2 TEL) and coloring an outlined
picture (5 EL, 5 TEL).
Table 3 Example of the ‘Making a telephone call’ activity divided into different core elements
Core element
Get the number Dial the number Make conversation and
end call
End task
Possible steps – Take a telephone book or mobile
phone
– Search the telephone number in
the mobile phone or phonebook
– Write the number on a piece
of paper
– Press the correct numbers
on the telephone to dial
the number
OR
– Select the correct name in
the telephone book of the
telephone
– Press the correct button to
make the telephone call
– Talk into the telephone
OR
– Talk into the telephone
using the ‘speaker’ function
– End the call by pressing the
correct button
– Place the telephone back
in the right position
– Put away the telephone
book and piece of paper
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After the last treatment session, therapists rated them-
selves on three items (therapeutic interaction, dealing
with errors and manual adherence). Each of these items
was scored on a six-point scale (1 = excellent, 2 = good,
3 = adequate, 4 = sufficient, 5 = insufficient, 6 = poor). On
average, therapists in both groups self-rated their inter-
vention adherence as ‘good’ (EL: mean 1.8, SD 0.4; TEL:
mean 2.0, SD 0.5). External raters used the same three
items and the same six-point scale to rate the therapists’
adherence, rating them on average as ‘good to excellent’
(EL: mean 1.5, SD 0.8; TEL: mean 1.6, SD 0.8). After
study completion we asked therapists for their assump-
tions about the superior learning technique. Six out of
eight EL therapists (three missing data) and three out of
10 TEL therapists rated the technique they had per-
formed as superior.
Outcomes
For the primary outcome, ITT analysis of the 140 partici-
pants with a week 16 follow-up assessment showed signifi-
cantly improved task performance of the self-selected task
A and task B in both groups from baseline to week 16
(standardized effect size (95% CI): task A, 0.61 (0.37–0.85);
task B, 0.47 (0.23–0.71)) and to week 26 (task A, 0.41
(0.17–0.64); task B, 0.26 (0.03–0.50)). No significant time
by treatment group interaction was found and no differ-
ences were found between task A and task B (Fig. 2 and
Table 5). The assumptions for multiple imputation were
fulfilled as the Missing Completely At Random Test (Lit-
tle’s MCAR test) showed a missing pattern completely at
random (χ2 = 102.4, df = 102, p = 0.471).
For secondary outcome and control measures, the pa-
tient’s need for assistance (measured with the IDDD),
Fig. 1 Flow of participants through the trial. IDDD Interview for Deterioration in Daily Living Activities, MMSE Mini Mental State Examination
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cognition (measured with the MMSE), challenging be-
havior (measured with the NPIQ) and Satisfaction with
Treatment verbal rating scale, as well as treatment costs
and resource utilization (measured with the RUD),
remained stable over 26 weeks and did not significantly
differ by treatment group or measurement time point
(Table 5). Patients of both groups rated satisfaction with
treatment as very good. Costs were similar for EL and
for TEL (€1907 and €1897, respectively) (see Additional
file 2: Table S2). Because we found no group differences
Table 4 Demographic and clinical characteristics at baseline
Errorless learning Trial and error learning
Completers
week 16 (n = 69)
Dropouts
week 16 (n = 12)
Total (n = 81) Completers
week 16 (n = 71)
Dropouts
week 16 (n = 9)
Total (n = 80)
Patient—demographic characteristics
Age (years) 76.7 (8.0) 79.3 (6.1) 77.1 (7.8) 76.2 (6.5) 75.2 (9.4) 76.1 (6.8)
Sex (female) 40 (58) 6 (50) 46 (57) 40 (56) 6 (67) 46 (58)
School
No school graduation 2 (2.9) 0 (0.0) 2 (2.5) 1 (1.4) 0 (0.0) 1 (1.3)
Middle school graduation
(9 or 10 years)
60 (87.0) 11 (91.7) 71 (87.7) 52 (73.2) 7 (77.8) 59 (73.8)
High school graduation
(12 or 13 years)
7 (10.1) 1 (8.3) 8 (9.9) 18 (25.4) 2 (22.2) 20 (25.0)
Vocational education
Not completed 17 (24.6) 2 (16.7) 19 (23.5) 12 (16.9) 3 (33.3) 15 (18.8)
Completed 52 (75.4) 10 (83.3) 62 (76.5) 59 (83.1) 6 (66.7) 65 (81.3)
Patient—clinical characteristics
TMT number of missing data 2 – 2 3 – 3
TMT number of not completed
(>240 sec)
19 2 21 12 1 13
TMT number of completed
(≤240 sec)
48 10 58 56 8 64
TMT completed (sec) 92.6 (40.9) 122.6 (61.6) 97.8 (45.9) 106.0 (50.8) 106.8 (45.3) 106.1 (49.8)
MMSE 19.8 (3.3) 19.1 (3.0) 19.7 (3.2) 19.7 (3.3) 20.3 (3.6) 19.8 (3.3)
Reisberg Clinical Dementia Rating 4.3 (0.6) 4.3 (0.5) 4.3 (0.7) 4.3 (0.7) 4.3 (0.7) 4.3 (0.7)
GDS 2.7 (1.7) 2.8 (1.9) 2.7 (1.9) 2.8 (2.2) 2.6 (2.1) 2.8 (2.2)
Years since dementia onset 2.2 (2.3) 1.8 (1.3) 2.1 (2.1) 1.5 (1.5) 3.3 (4.3) 1.7 (2.1)
Number of patients without
additional diagnosis
27 (39.1) 4 (33.3) 31 (38.3) 30 (42.3) 4 (44.4) 34 (42.5)
Number of patients with
1–3 additional diagnoses
33 (47.8) 6 (50.0) 39 (48.1) 33 (46.5 4 (44.4) 37 46.3)
Number of patients with
≥4 additional diagnoses
9 (13.0) 2 (16.7) 11 (13.6) 8 (11.3) 1 (11.1) 9 (11.3)
Primary caregiver
Age (years) 62.3 (13.5) 65.4 (12.9) 62.7 (13.4) 62.9 (13.8) 60.2 (12.5) 62.6 (13.6)
Sex (female) 25 (36.2) 4 (33.3) 29 (35.8) 26 (36.6) 3 (33.3) 29 (36.3)
Relation
Spouse 35 (50.7) 7 (58.3) 42 (51.9) 41 (57.7) 4 (44.4) 45 (56.3)
(Grand) Child 30 (43.5) 4 (33.3) 34 (42.0) 27 (38.0) 5 (55.6) 32 (40.0)
Others 4 (5.8) 1 (8.3) 5 (6.2) 3 (4.2) 0 (0.0) 3 (3.8)
Living together 47 (68.1) 9 (75.0) 56 (69.1) 47 (66.2) 5 (55.6) 52 (65.0)
Caring for the patient
(months)
26.4 (26.8) 33.1 (34.9) 27.4 (28.0) 21.9 (18.7) 33.4 (37.2) 23.2 (21.5)
Data presented as mean (standard deviation) or number (percentage)
TMT Trial Making Test, MMSE Mini Mental State Examination, GDS Geriatric Depressions Scale
Voigt-Radloff et al. Alzheimer's Research & Therapy  (2017) 9:22 Page 7 of 11
at baseline or after the intervention on any of the con-
trol measures (Table 5), we did not use them for adjust-
ing the primary outcome for confounding.
Study sites reported four serious adverse events in the
EL group (one death, one nonelective hospital admis-
sion, two nursing home admissions) and five in the TEL
group (one death, two nonelective hospital admissions,
two nursing home admissions). Study site leaders judged
all serious adverse events as unrelated to the study treat-
ment or assessment.
Discussion
This is the first large RCT on EL as a method to teach
persons with dementia activities of daily living in their
own environment. The objective of this multicenter
REDALI-DEM trial was to evaluate whether EL or TEL
demonstrates superior effects on the performance of two
relevant activities of daily living in persons with mild to
moderate AD living at home. Results showed an im-
proved post-treatment performance of daily living tasks
in both arms, but EL was not found to be superior to
TEL. The relearning of activities did not affect the pa-
tients’ initiative or need for assistance in activities of
daily living. Both EL and TEL were very well accepted
by the patients and the costs did not differ between both
treatments. Although serious adverse events occurred,
these were judged unrelated to the intervention. The fact
that improved task performance in both treatment arms
did not lead to improvement on secondary outcomes
indicates that no generalization effects on daily life
functioning were found, but only improvements on the
trained tasks. Note that the lack of to be expected
generalization effects has been put forward as a limita-
tion of EL previously [4].
These results are not in agreement with most earlier
findings on the effects of EL, because previous reviews
on EL suggested superior results for EL compared with
TEL. However, most previous studies were small-scale
trials or proof-of-principle studies in which patients
were taught artificial tasks that had marginal relevance
to them (such as learning an artificial word list). Our
hypothesis that EL would be a more effective teaching
method for persons with dementia was based on these
earlier findings. However, this hypothesis is not con-
firmed in this first adequately powered, rigorously
designed and well-performed multicenter RCT.
Recent studies that have used procedural tasks or skills
to examine the effects of EL in patients with dementia
showed mixed results [5, 17]. One explanation for these
mixed findings may lie in the nature of the tasks. That
is, there is some evidence that EL works through the fa-
cilitation of implicit, automatic learning processes, which
have been shown to be intact in patients with dementia
[18]. Possibly, the procedural nature of the tasks that
were trained in the current RCT may in itself have
already facilitated learning, irrespective of the error re-
duction aspect. Indeed, learning has taken place in both
treatment arms, which is in line with this view. More-
over, both treatment procedures could be categorized as
forms of ‘structured learning’. That is, therapists adopted
a step-by-step approach, provided feedback and stimu-
lated engagement in the task. This structuring may have
optimized learning in itself, resulting in better post-
treatment task performance, an effect that was also
maintained at the follow-up assessment. In addition, to
measure our primary outcome a recently developed rat-
ing scale was used: the Core Elements Method (CEM).
The pilot phase was therefore also used to validate this
newly developed outcome measure. The interrater reli-
ability and concurrent validity of the CEM and TPS were
analyzed and compared [7]. Based on these results, the
TPS and CEM were found to be equally valid for the as-
sessment of task performance in people with dementia.
However, the CEM was found to be less complex and
less time-consuming compared with the TPS, and there-
fore used in the current RCT. Although result from this
previous pilot phase showed excellent validity and reli-
ability, the current results have to be interpreted with
some caution because its psychometric properties have
only been examined in one study.
Strengths of the current study include the naturalistic
setting of the intervention. That is, the intervention was
carried out in the patients’ own homes, using tasks that
were relevant for them to acquire. Patients also appreci-
ated the intervention very much. This may have also
promoted learning in both arms, obscuring a potential
superior effect of error reduction. In addition, the large
sample size and the low drop-out rate can be considered
strengths of the study. The low drop-out rate prevented
attrition bias and justifies that we did not include all
Fig. 2 Primary outcome measure (performance on task A and task B;
mean + SEM) for the errorless (EL) and trial and error (TEL) treatment
arms at baseline and weeks 11, 16 and 26
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randomized patients in our ITT analysis, but only those
with data for at least at two time points (baseline and
primary outcome time point at week 16). Data imput-
ation for participants with data for only one time point
is prone to adverse events (three patients). Note that all
other dropouts withdrew their consent.
All persons involved were blinded to our hypotheses
and the raters who assessed the primary outcome were
also fully blinded to treatment arms and the hypothesis.
Treatment adherence of the therapists was monitored
using self-ratings and external ratings, showing good
treatment adherence. The planned sample size was
reached in this RCT and the findings are reported ac-
cording to the CONSORT guidelines [19], including
long-term results, treatment costs and adverse events.
Limitations include the heterogeneity of the tasks that
were trained. Tasks like making a grocery list or plan-
ning a trip may have had more degrees of freedom than
straightforward ‘stimulus-response’ tasks such as dialing
a telephone number or playing a DVD. A methodo-
logical limitation was that patients and therapists by def-
inition were not blinded to the treatment itself, although
measures were taken to prevent cross-over effects by let-
ting therapists give only one type of intervention.
Conclusion and future research
Persons with dementia can still be retrained in perform-
ing activities of daily living using structured learning,
with effects being maintained for 6 months. However,
EL had no additional effect over TEL. Future research
should examine whether the effectiveness of structured
learning depends on patient-specific or task-specific
characteristics.
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